Results 101-120 of 1,490 for drugs speaker:Stephen Donnelly

Select Committee on Health: Estimates for Public Services 2023
Vote 38 - Health (Supplementary) (29 Nov 2023)

Stephen Donnelly: ...to respond on what we think is likely to happen next year. The Deputy will be aware that we are observing very high inflation this year. It depends area by area. Medical and surgical devices, drugs and medicines, catering and heating are different but we are looking at a range of figures - 10%, 17%, 23%. I will ask the officials to give a view on our best guess as to what might happen...

Select Committee on Health: Estimates for Public Services 2023
Vote 38 - Health (Supplementary) (29 Nov 2023)

Stephen Donnelly: ...a new rare disease strategy. Advocacy groups such as Rare Diseases Ireland are very involved. We are pulling people into this. Something we need for that is funding for new medicines, orphan drugs. We intend going after that in a very hard-nosed manner by finding savings in that €3.2 billion figure. The work has already started and will be governed under the productivity task...

Written Answers — Department of Health: Departmental Bodies (28 Nov 2023)

Stephen Donnelly: ...of Health officials in 2023. The Department met with PSI in March and September of this year and are due to meet again in December. Within the Department of Health, Medicines, Controlled Drugs and Pharmacy Legislation Unit (MCDPLU) is the main point of contact for the PSI, though other units may engage with the PSI as required, dependent on business needs. MCDPLU also liaises with the...

Written Answers — Department of Health: Departmental Meetings (28 Nov 2023)

Stephen Donnelly: ...Policy and Action Plan (OPAP) Food Labelling Wellbeing Healthy Eating Guidelines for 1-5 Year Olds Department of Health Frank Feighan, T.D. Minister for Public Health, Wellbeing & the National Drugs Strategy Blaine Gaffney, Minister Feighan’s Office Audrey Hagerty, (Principal Officer) Ciara Mellett, (Head of Healthy Ireland Programme) Ursula O’Dwyer,...

Written Answers — Department of Health: Medicinal Products (28 Nov 2023)

Stephen Donnelly: ...to take Questions Nos. 595, 597, 598 and 599 together. The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drugs schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. The HSE is committed to providing access to as many medicines as possible, in as timely a fashion...

Written Answers — Department of Health: Medicinal Products (28 Nov 2023)

Stephen Donnelly: ...reimbursement from EMA approval to HSE reimbursement approval does not consider this important factor and misrepresents the process, as statutorily the HSE would not be able to approve or assess a drug until an application for reimbursement was received. When an application is made to have a product added to the reimbursement list in Ireland, the HSE is required, under the 2013 Act,...

Written Answers — Department of Health: Health Services (28 Nov 2023)

Stephen Donnelly: ...diabetes mellitus; parkinsonism; epilepsy; phenylketonuria; haemophilia; spina bifida; hydrocephalus; and conditions arising from the use of Thalidomide. Under the LTI Scheme, patients receive drugs, medicines, and medical and surgical appliances directly related to the treatment of their condition, free of charge. Statutory Instrument No. 277 of 1971, place the following...

Written Answers — Department of Health: Health Services (22 Nov 2023)

Stephen Donnelly: ...in the country, i.e. full eligibility (medical card holders) and limited eligibility (all others). Adults with full eligibility can access a range of services including GP services, prescribed drugs and medicines, public in-patient hospital services, including consultants’ services, out-patient public hospital services including consultants’ services, dental, ophthalmic and...

Written Answers — Department of Health: Tobacco Control Measures (22 Nov 2023)

Stephen Donnelly: ..., Government removed VAT on all nicotine replacement therapies thus reducing the cost of these products to people who wish to stop smoking. I have also agreed that nicotine replacement therapies should be included in the Drug Payment Scheme and to remove the two week limit that applied to first prescriptions of these therapies. It should also be noted that as part of Budget 2024...

Written Answers — Department of Health: Medical Aids and Appliances (22 Nov 2023)

Stephen Donnelly: ...certain expenses. In circumstances where an applicant is still over the income limit for a medical card, they are then assessed for a GP visit card, which entitles the applicant to GP visits without charge. The Drug Payment Scheme (DPS) ensures that no individual or family pays more than €80 a month towards the cost of approved prescribed medicines. The DPS significantly reduces...

Written Answers — Department of Health: Vaccination Programme (21 Nov 2023)

Stephen Donnelly: ...will continue to be amended over time. Shingles vaccination is not currently provided as part of the national immunisation programme. The vaccine is not available through the medical card or drug payment schemes. Further information is available here: www2.hse.ie/conditions/shingles/ It is open to any individual who is aged 50 years and older and who wishes to receive the vaccine to...

Written Answers — Department of Health: Departmental Data (21 Nov 2023)

Stephen Donnelly: ...in relation to the situation in Gaza and Israel on 13 October 2023.My Department also receives copies of licenses from the Israeli Ministry of Health in respect of the import/export of controlled drugs between Ireland and Israel. Details for other bodies under the aegis of my Department are operational matters for the bodies concerned and the Deputy should contact the relevant...

Written Answers — Department of Health: Medicinal Products (21 Nov 2023)

Stephen Donnelly: ...€100 million of dedicated funding has been invested by the State in new medicines funding to provide 127 new medicines or extended uses for medicines, to include 50 medicines for oncology and 39 orphan drugs for the treatment of rare diseases.

Written Answers — Department of Health: Medicinal Products (21 Nov 2023)

Stephen Donnelly: Part 3 of the 2013 Health (Pricing and Supply of Medical Goods) Act outlines the criteria that the HSE are required to consider when making decisions on reimbursement of drugs. The Executive shall have regard to— (a) the health needs of the public, (b) the cost-effectiveness of meeting health needs by supplying the item concerned rather than providing other health services,...

Written Answers — Department of Health: Medicinal Products (21 Nov 2023)

Stephen Donnelly: .... The NCPE is also leading on the development of methodological guidelines on behalf of the EU Member State Coordination Group on HTA, for joint assessments on the comparative effectiveness of drugs.

Written Answers — Department of Health: Medicinal Products (21 Nov 2023)

Stephen Donnelly: ...;45,000 per QALY. While the threshold values are not explicitly stated in the current Framework Agreement, the NCPE assessments present results of cost-effectiveness analyses for consideration by the HSE Drugs Group using both of these threshold values.

Written Answers — Department of Health: Pharmacy Services (16 Nov 2023)

Stephen Donnelly: ..., are working on the implementation of this recommendation. From the 1stof March 2024, the legal validity of prescriptions will be 12 months, with exceptions for some medications such as controlled drugs. Doctors and relevant prescribers such as nurses and dentists will be enabled to write prescriptions for a patient with a legal validity of up to 12 months if they deem it clinically...

Written Answers — Department of Health: Medical Cards (16 Nov 2023)

Stephen Donnelly: The Health Service Executive (HSE) has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013. Reimbursement is for licenced indications which have been granted market authorisation by the European Medicines Agency (EMA) or the Health...

Written Answers — Department of Health: Medical Cards (15 Nov 2023)

Stephen Donnelly: ...(medical card holders) and limited eligibility (all others). People with full eligibility (medical card holders) can currently access a range of services including GP services, prescribed drugs and medicines, public in-patient hospital services, including consultants’ services, out-patient public hospital services including consultants’ services, dental, ophthalmic and...

Written Answers — Department of Health: Disease Management (9 Nov 2023)

Stephen Donnelly: ...not on the Reimbursement List. In some cases, this will require a hospital prescription, or a recommendation from a HSE Tissue Viability Nurse. All dressings on the Reimbursement list are also available under the Drugs Payment Scheme.